Say Goodbye to Your Smartphone
According to Microsoft engineer Alex Kipman, “Smartphones are yesterday's news. The phone is already dead. People just haven't realized.”

And it’s all thanks to the device inside this black box…
Click here to see it in action.
Stephen L. Silvestro, insider at OptimizeRx
Stephen L. Silvestro Insider Alerts

Get notified the next time Stephen L. Silvestro buys or sells OptimizeRx stock. Enter your email address below to get our daily insider buying and selling report.

Stephen L. Silvestro Insider Information

Insider of OptimizeRx

Steve Silvestro brings more than 20 years of experience in direct operations, sales, and partner network growth, to lead revenue activities and strengthen the go-to-market.

Steve is responsible for driving OptimizeRx's platform revenue growth including enterprise-level direct-to-patient and direct-to-provider product adoption to improve patient outcomes.

During his tenure at Decision Resources Group, he was an instrumental leader in the growth of the company from $30 million to $180 million in revenue. His customer-first philosophy is greatly aligned to our values at OptimizeRx.  

Steve previously served as vice president and general manager at CCH Tagetik, a division of Wolters Kluwer. Prior pharma leadership experience includes executive positions with Prognos, Decision Resources Group, and D.M.S. Silvestro has extensive channel expertise in biopharma commercialization, global market access, market research, analytics, enterprise SaaS solutions, and strategy.  

Silvestro received a master’s degree in Business Management from Harvard University. He also holds undergraduate degrees from Brigham Young University in both Business and Italian. He is fluent in English, Italian, Spanish and conversational in French. 

What is Stephen L. Silvestro's net worth?

The estimated net worth of Stephen L. Silvestro is at least $606,748.44 as of July 20th, 2021. Mr. Silvestro owns 13,242 shares of OptimizeRx stock worth more than $606,748 as of January 20th. This net worth evaluation does not reflect any other assets that Mr. Silvestro may own. Learn More.

What is Stephen L. Silvestro's salary?

As the Insider of OptimizeRx Co., Mr. Silvestro earned a total compensation package of $1,120,199.00 in 2019. Mr. Silvestro earned a salary of $188,821.00, a bonus of $82,678.00, stock awards of $938,700.00, and no other miscellaneous compensation.

How do I contact Stephen L. Silvestro?

The corporate mailing address for Mr. Silvestro and other OptimizeRx executives is 400 WATER STREET SUITE 200, ROCHESTER MI, 48307. OptimizeRx can also be reached via phone at (248) 651-6568 and via email at [email protected]

Has Stephen L. Silvestro been buying or selling shares of OptimizeRx?

Stephen L. Silvestro has not been actively trading shares of OptimizeRx over the course of the past ninety days. Most recently, Stephen L. Silvestro sold 13,242 shares of the business's stock in a transaction on Tuesday, July 20th. The shares were sold at an average price of $50.34, for a transaction totalling $666,602.28. Following the completion of the sale, the insider now directly owns 13,242 shares of the company's stock, valued at $666,602.28.

Who are OptimizeRx's active insiders?

OptimizeRx's insider roster includes Douglas Baker (CFO), William Febbo (CEO), Miriam Paramore (Insider), and Stephen Silvestro (Insider).

Are insiders buying or selling shares of OptimizeRx?

During the last twelve months, insiders at the sold shares 35 times. They sold a total of 460,064 shares worth more than $27,570,342.42. The most recent insider tranaction occured on December, 17th when insider Stephen L Silvestro sold 13,241 shares worth more than $726,533.67. Insiders at OptimizeRx own 6.5 % of the company.

Information on this page was last updated on 12/17/2021.

Stephen L. Silvestro Insider Trading History at OptimizeRx

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/20/2021Sell13,242$50.34$666,602.2813,242View SEC Filing Icon  
5/17/2021Sell13,242$42.72$565,698.24View SEC Filing Icon  
See Full Table

Stephen L. Silvestro Buying and Selling Activity at OptimizeRx

This chart shows Stephen L. Silvestro's buying and selling at OptimizeRx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

OptimizeRx Company Overview

OptimizeRx logo
OptimizeRx Corp. is digital health company, which engages in the provision of digital health messaging via electronic health records, which serves as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging; and brand support. The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Rochester, MI.
Read More

Today's Range

Now: $45.82
Low: $44.93
High: $46.69

50 Day Range

MA: $61.39
Low: $45.82
High: $87.22

2 Week Range

Now: $45.82
Low: $39.06
High: $99.18

Volume

465,246 shs

Average Volume

290,904 shs

Market Capitalization

$814.22 million

P/E Ratio

327.29

Dividend Yield

N/A

Beta

0.55
5 Free Dividend Stocks for 2022
Could these top payout stocks be part of the greatest wealth-creating tool in history?
Learn More.